Alkermes (ALKS) executive Hopkinson acquired 7,689 shares
Insider transactions reported
Craig C. Hopkinson (EVP R&D, Chief Medical Officer at Alkermes plc, ALKS) reported that they acquired 7,689 shares, and gave up 3,414 shares at $32.19 to cover taxes or an exercise price on Feb 23, 2026. After these transactions the filing shows 89,572 shares held directly.
- Reporting person
- Hopkinson Craig C.
- Role
- EVP R&D, Chief Medical Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Exercise or conversion of a derivative (M) | Ordinary Shares1 | +7,689 | - | - | 92,986 direct |
| Feb 23, 2026 | Shares withheld for taxes or exercise price (F) | Ordinary Shares | -3,414 | $32.19 | $110K | 89,572 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Exercise or conversion of a derivative (M) | Restricted Stock Unit AwardOn 7,689 Ordinary Shares1, 2 | -7,689 | - | - | 7,690 direct |
Holdings before and after
- Ordinary Shares: 85,297 to 89,572 direct
- Restricted Stock Unit Award: 15,379 to 7,690 direct
Footnotes from the filing
- 1. Each restricted stock unit represents a contingent right to receive one ordinary share.
- 2. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Hopkinson report in this ALKS Form 4?
Craig C. Hopkinson (EVP R&D, Chief Medical Officer at Alkermes plc, ALKS) reported that they acquired 7,689 shares, and gave up 3,414 shares at $32.19 to cover taxes or an exercise price on Feb 23, 2026. After these transactions the filing shows 89,572 shares held directly.
How many ALKS shares does Hopkinson hold after this filing?
The filing shows 89,572 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for ALKS
Across the 13 sessions after earlier ALKS headlines, the stock closed higher 9 times and lower 4 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ALKS | SPY |
|---|---|---|---|
| Feb 25, 2026 | Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026and 2 other headlines that session | -7.0% | +0.8% |
| Feb 24, 2026 | Wolfe Research initiated coverage on Alkermes Plc with a new price target | +3.7% | +0.7% |
| Feb 12, 2026 | Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 | -4.6% | -1.5% |
| Jan 6, 2026 | Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1 | +2.8% | +0.6% |
| Dec 31, 2025 | Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference | +0.6% | -0.7% |
| Nov 26, 2025 | Alkermes to Participate in Two Upcoming Investor Conferences | +2.5% | +0.7% |
Earlier insider filings at ALKS
- Feb 25, 2026EVP, CLO, Alkermes, Inc. Gaffin David Joseph converted options into 7,689 units of Ordinary Shares and covered exercise/tax liability with 3,414 units of Ordinary Shares, increasing direct ownership by 2% to 235,877 units (SEC Form 4)
- Feb 20, 2026VP, Finance (Interim PAO) Parisi Samuel Joseph converted options into 5,025 units of Ordinary Shares and covered exercise/tax liability with 1,685 units of Ordinary Shares, increasing direct ownership by 43% to 11,057 units (SEC Form 4)
- Feb 20, 2026SVP, Chief Commercial Officer Nichols Christian Todd converted options into 12,400 units of Ordinary Shares and covered exercise/tax liability with 4,146 units of Ordinary Shares, increasing direct ownership by 8% to 109,200 units (SEC Form 4)
- Feb 20, 2026EVP, Chief Operating Officer Jackson Blair Curtis converted options into 18,197 units of Ordinary Shares and covered exercise/tax liability with 7,926 units of Ordinary Shares, increasing direct ownership by 5% to 231,823 units (SEC Form 4)
- Feb 20, 2026EVP R&D, Chief Medical Officer Hopkinson Craig C. converted options into 16,570 units of Ordinary Shares and covered exercise/tax liability with 6,911 units of Ordinary Shares, increasing direct ownership by 13% to 85,297 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 1991
Follow ALKS and get a push notification the moment its next story breaks.